Inhibition of T helper 2 chemokine production by narrowband ultraviolet B in cultured keratinocytes

British Journal of Dermatology

Volumn 156, Issue 5, 2007, Pages 830-837

  Hino, R ^a   Kobayashi, M ^a   Mori, T ^a   Orimo, H ^a   Shimauchi, T ^a   Kabashima, K ^a   Tokura, Y ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Chemokine; Cytokine; Keratinocyte; Ultraviolet B

Indexed keywords

CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1ALPHA; MACROPHAGE DERIVED CHEMOKINE; MESSENGER RNA; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHEMOTAXIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOREGULATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; TH1 CELL; TH2 CELL; ULTRAVIOLET B RADIATION;

CHEMOKINES; CYTOKINES; HUMANS; INTERLEUKIN-1ALPHA; KERATINOCYTES; RNA, MESSENGER; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET RAYS;

EID: 34247397930     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07774.x     Document Type: Article

References (32)

1. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981 76:359 62.
2. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy - an effective treatment for psoriasis. Br J Dermatol 1988 119:691 6.
3. Tanew A, Radakovic-Fijan S, Schemper M, Hönigsmann H. Narrowband UV-B phototherapy vs. photochemotherapy in the treatment of chronic plaque-type psoriasis. Arch Dermatol 1999 135:519 24.
4. Gathers RC, Scherschun L, Malick F et al. Narrowband UVB phototherapy for early-stage mycosis fungoides. J Am Acad Dermatol 2002 47:191 7.
5. Der-Petrossian M, Seeber A, Hönigsmann H, Tanew A. Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 2000 142:39 43.
6. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001 44:999 1003.
7. Bilsland D, George SA, Gibbs NK et al. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 1993 129:708 12.
8. Gibbs NK, Traynor NJ, MacKie RM et al. The phototumorigenic potential of broad-band (270-350 nm) and narrow-band (311-313 nm) phototherapy source cannot be predicted by their edematogenic potential in hairless mouse skin. J Invest Dermatol 1995 104:359 63.
9. Orimo H, Tokura Y, Hino R, Kasai H. Formation of 8-hydroxy-2′- deoxyguanosine in the DNA of cultured human keratinocytes by clinically used doses of narrowband and broadband ultraviolet B and psoralen plus ultraviolet A. Cancer Sci 2006 97:99 105.
10. British Photodermatology Group. An appraisal of narrowband (TL-01) UVB phototherapy. Br J Dermatol 1997 137:327 30.
11. Young AR. Carcinogenicity of UVB phototherapy assessed. Lancet 1995 345:1431 2.
12. Kupper TS, Chua AO, Flood P et al. Interleukin-1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J Clin Invest 1987 80:430 6.
13. Kondo S, Sauder DN, Kono T et al. Differential modulation of interleukin-1α (IL-1α) and interleukin-1β (IL-1β) in human epidermal keratinocytes by UVB. Exp Dermatol 1994 3:29 39.
14. Schwarz A, Bhardwaj R, Aragane Y et al. Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-α in the formation of sunburn cells. J Invest Dermatol 1995 104:922 7.
15. McLoone P, Man I, Yule S et al. Whole-body UVB (TL-01) or UVA-1 irradiation does not alter the levels of immunomodulatory cytokines in the serum of human volunteers. Photodermatol Photoimmunol Photomed 2004 20:76 80.
16. Sigmundsdottir H, Johnston A, Gudjonsson JE, Valdimarsson H. Narrowband-UVB irradiation decreases the production of proinflammatory cytokines by stimulated T cells. Arch Dermatol Res 2005 297:39 42.
17. Rossi D, Zlotnic A. The biology of chemokines and their receptors. Annu Rev Immunol 2000 18:217 42.
18. Kobayashi M, Shimauchi T, Hino R, Tokura Y. Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors. Cell Immunol 2004 228:27 33.
19. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998 187:875 83.
20. Boukamp P, Petrussevska RT, Breitkreutz D et al. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988 106:761 71.
21. Gordon PM, Saunders PJ, Diffey BL, Farr PM. Phototesting prior to narrowband (TL-01) ultraviolet B phototherapy. Br J Dermatol 1998 139:811 14.
22. Cousins DJ, Lee TH, Staynov DZ. Cytokine coexpression during human Th1/Th2 cell differentiation: direct evidence for coordinated expression of Th2 cytokines. J Immunol 2002 169:2498 506.
23. Tsuda T, Tohyama M, Yamasaki K et al. Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro. J Dermatol Sci 2003 31:37 42.
24. Kraft M, Riedel S, Maaser C et al. IFN-γ synergizes with TNF-α but not with viable H. pylori in up-regulating CXC chemokine secretion in gastric epithelial cells. Clin Exp Immunol 2001 126:474 81.
25. Granstein RD, Margolis R, Mizel SB, Sauder DN. In vivo inflammatory activity of epidermal cell-derived thymocyte activating factor and recombinant interleukin 1 in the mouse. J Clin Invest 1986 77:1020 7.
26. Leung DY. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995 96:302 18.
27. Tokura Y, Yagi H, Hanaoka K et al. Subacute and chronic prurigo effectively treated with recombination interferon-γ: implications for participation of Th2 cells in the pathogenesis of prurigo. Acta Derm Venereol (Stockh) 1997 77:231 4.
28. Fushimi M, Tokura Y, Sachi Y et al. Eosinophilic pustular folliculitis effectively treated with recombinant interferon-γ: suppression of mRNA expression of interleukin 5 in peripheral blood mononuclear cells. Br J Dermatol 1996 134:766 72.
29. Schlaak JF, Buslau M, Jochum W et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994 102:145 9.
30. Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol 2001 45:487 98.
31. Krueger JG, Wolfe JT, Nabeya RT et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 1995 182:2057 68.
32. Ozawa M, Ferenczi K, Kikuchi T et al. 312-nanometer ultraviolet B light (narrow-band UVB) induces apoptosis of T cells within psoriatic lesions. J Exp Med 1999 189:711 18.